Peter Welford

Stock Analyst at Jefferies

(2.18)
# 2,508
Out of 4,818 analysts
13
Total ratings
60%
Success rate
4.82%
Average return

Stocks Rated by Peter Welford

GSK plc
Nov 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $37.50
Upside: -
Novartis AG
Sep 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $111.17
Upside: -
AstraZeneca
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $69.55
Upside: -
Galapagos NV
Jan 23, 2023
Upgrades: Hold
Price Target: $49$47
Current: $26.49
Upside: +78.18%
Genmab
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $20.54
Upside: -